At the Annual Meeting held on May 29, 2019, the Company’s stockholders took the following actions: (1) elected eight directors to serve on the board of directors until the Company’s next annual meeting of stockholders or until their respective successors have been elected and qualified; (2) approved, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the proxy statement (the “Say on Pay Vote”); (3) approved an amendment to the Company’s Amended and Restated 2017 Long-Term Incentive Plan (“LTIP”) to increase by 2,300,000 the number of shares of common stock authorized for issuance under the LTIP; and (4) ratified the selection of Deloitte & Touche LLP to serve as the Company’s independent registered public accounting firm for the year ending December 31, 2019. For more information about the foregoing proposals, see the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 18, 2019, the relevant portions of which are incorporated herein by reference.

The number of shares of common stock entitled to vote at the Annual Meeting was 62,260,163. The number of shares of common stock present or represented by valid proxy at the Annual Meeting was 54,284,167. The voting results for each proposal are set forth below.

Proposal 1. Election of Directors

All eight director nominees were elected, each having received more votes cast for than against his or her election, and will serve as directors until the Company’s next annual meeting of stockholders or until their respective successors have been elected and qualified. The votes cast for, against or abstained with respect to each nominee and the number of broker non-votes with respect to each nominee were as follows:

Proposal 2. Advisory Vote on Executive Compensation (the “Say on Pay Vote”)

Stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Company’s proxy statement, including the Compensation Discussion and Analysis, the executive compensation tables, and the related narrative. There were 48,769,168>(or 94.9%) votes cast for this proposal, and 2,609,687>(or 5.1%) votes against it, with 38,023 votes abstaining and 2,867,289 broker non-votes.

Proposal 3. Approval of Amendment to the Company’s Amended and Restated 2017 Long-Term Incentive Plan

Stockholders approved an amendment to the Company’s Amended and Restated 2017 Long-Term Incentive Plan (“LTIP”) to increase by 2,300,000>the number of shares of common stock available for issuance under the LTIP. The results of the voting included 48,549,159 (or 94.5%) votes for, 2,827,668 (or 5.5%) votes against, 40,051 votes abstaining, and 2,867,289 broker non-votes.

Proposal 4. Ratification of Appointment of Independent Registered Public Accounting Firm

Stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2019. The results of the voting included 53,553,841>(or 98.7%) votes for, 699,485 (or 1.3%) votes against, and 30,841 votes abstaining.

About Medidata Solutions, Inc. (NASDAQ:MDSO)

Medidata Solutions Inc. (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Medidata Clinical Cloud provides a platform of technology and data analytics solutions designed to manage activities across clinical development. Its Planning Cloud provides capabilities for study design and planning, enabling customers to make use of resources through planning at the start of trial design and protocol development. Specific functionality supports visibility into the impact of protocol elements on resource and trial endpoints; comparisons to specific industry benchmarks, and analytics to support appropriate grants to investigator sites and automated negotiations with multiple investigator sites. Data Capture Cloud is Medidata’s electronic data capture (EDC) and its management system solution is Medidata Rave.